Article Text

Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
Quinacrine induced mood disturbance – the unmasking of bipolar affective disorder
  1. John Lally1,
  2. Fintan Byrne2,
  3. Elizabeth Walsh3
  1. 1Department of Psychiatry, National University of Ireland, Galway (NUIG), Galway, Ireland
  2. 2West Galway Mental Health Services, Galway, Ireland
  3. 3Health Service Executive West, West Galway Mental Health Services, Galway, Ireland
  1. Correspondence to Dr John Lally, john.lally{at}nuigalway.ie

Summary

The authors report the case of a 20-year-old man who presented with a de novo episode of hypomania subsequent to the initiation of quinacrine for treatment resistant giardiasis. The hypomanic episode commenced some 20 days after the successful completion of a week long course of quinacrine 100 mg three times daily. The hypomanic episode was treated with olanzapine 10 mg daily. Two months subsequent to this, the patient developed a moderate depressive episode which was treated with escitalopram and olanzapine. One month after the resolution of the depressive episode, he once again presented with a hypomanic episode. The recurring episodes of discrete mood disturbance all occurred within 5 months of the commencement of quinacrine in an individual with no personal history of affective disorders.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.